HLA基因-药物/疾病关联数据分析报告

人类白细胞抗原（HLA）基因-药物/疾病关联数据分析报告，基于PharmGKB数据库、PubMed数据库、NICE和NGC数据库、FDA和NMPA官网等数据源，通过人工筛选、录入、双人审核与校对等方法，总计分析约6000篇文献的数据，展示了HLA基因与药物疗效、不良反应之间的关联信息，以及HLA不同等位基因对自身免疫性疾病、病毒感染性疾病、肿瘤或癌症及移植等疾病的影响。Data Analysis Report on Human Leukocyte Antigen (HLA) Gene-Drug and Disease Associations. This report is based on data sources including the PharmGKB database, PubMed database, NICE and NGC databases, as well as the official websites of FDA and NMPA. By employing methods such as manual screening, data entry, dual review and proofreading, data from approximately 6,000 published papers were comprehensively analyzed. The report presents the association information between HLA genes and drug efficacy or adverse drug reactions, as well as the impacts of different HLA alleles on various diseases including autoimmune diseases, viral infectious diseases, tumors or cancers, and transplantation-related conditions.

搜集汇总

背景与挑战

背景概述

该数据集为HLA基因-药物/疾病关联数据分析报告，基于PharmGKB、PubMed等权威数据库，通过人工筛选和双人审核，分析了约6000篇文献，展示了HLA基因与药物疗效、不良反应的关联，以及HLA基因对自身免疫性疾病、肿瘤等多种疾病的影响，适用于智慧医疗领域的生物标志物研究。